Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019204 (
hepatocellular carcinoma
)
71,386
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The incidence of
hepatoma
is high in the Chinese population. Searching for genes involved in the functions of the liver, especially genes specifically expressed in the liver, will facilitate an insight into the molecular basis of normal and abnormal liver functions. Based on a differentially displayed cDNA fragment, which was down regulated in
hepatoma
tissues, we cloned a novel cDNA of 957 bp,
TCP10L
(T-complex protein 10 like), from the human liver cDNA library. Northern hybridization of this novel gene in 30 adult human tissues was examined. The result revealed that
TCP10L
expressed specifically in the human liver and testis. The
TCP10L
contains a 645-bp open reading frame encoding a deduced protein of 215 amino acids. As the deduced protein was analyzed further, a typical leucine zipper motif was found. We firstly examined the transcriptional function of the TCP10L protein by transfecting recombinant pM-
TCP10L
into mammalian cells. The subsequent analysis based on the dual luciferase assay system showed that
TCP10L
significantly inhibited the expression of reporter genes. Compared with that of the negative control, the luciferase activity were down regulated in HEK293 and SK-HEP-1, CHO cells by about 2.6, 9.8, and 5.5 folds respectively. A mutated type of
TCP10L
was also constructed. It showed that the repression of
TCP10L
to the expression of the reporter gene almost completely decreased, suggesting that the leucine zipper structure is critical for
TCP10L
to play its role in regulation function. Then we transfected the recombinant
TCP10L
-EGFP into cells. The results indicated that
TCP10L
subcellularly located in nuclei, either in HEK 293 or SK-HEP-1 cells. In addition, human
TCP10L
was found comprised of five exons and four introns, and mapped to chromosome 21q22.11.
...
PMID:Identification of a novel liver-specific expressed gene, TCP10L, encoding a human leucine zipper protein with transcription inhibition activity. 1458 71
TCP10L
(T-complex 10 (mouse)-like) has been identified as a liver and testis-specific gene. Although a potential transcriptional suppression function of
TCP10L
has been reported previously, biological function of this gene still remains largely elusive. In this study, we reported for the first time that
TCP10L
was significantly down-regulated in clinical
hepatocellular carcinoma
(
HCC
) samples when compared to the corresponding non-tumorous liver tissues. Furthermore,
TCP10L
expression was highly correlated with advanced cases exceeding the Milan criteria. Overexpression of
TCP10L
in
HCC
cells suppressed colony formation, inhibited cell cycle progression through G0/G1 phase, and attenuated cell growth in vivo. Consistently, silencing of
TCP10L
promoted cell cycle progression and cell growth. Therefore, our study has revealed a novel suppressor role of
TCP10L
in
HCC
, by inhibiting proliferation of
HCC
cells, which may facilitate the diagnosis and molecular therapy in
HCC
.
...
PMID:TCP10L acts as a tumor suppressor by inhibiting cell proliferation in hepatocellular carcinoma. 2456 46
Alpha-fetoprotein (AFP) is one of the most commonly used and reliable biomarkers for
Hepatocellular carcinoma
(
HCC
). However, the underlying mechanism of AFP expression in
HCC
is poorly understood. In this study, we found that
TCP10L
, a gene specifically expressed in the liver, is down-regulated in
HCC
and that its expression inversely correlates with AFP expression. Moreover, overexpression of
TCP10L
suppresses AFP expression whereas knockdown of
TCP10L
increases AFP expression, suggesting that
TCP10L
might be a negative regulator of AFP. We found that
TCP10L
is associated with the AFP promoter and inhibits AFP promoter-driven transcriptional activity. Taken together, these results indicate that
TCP10L
negatively regulates AFP expression in
HCC
and that it could be a potential prognostic marker and therapeutic target for
HCC
. [BMB Reports 2020; 53(8): 431-436].
...
PMID:TCP10L negatively regulates alpha-fetoprotein expression in hepatocellular carcinoma. 3243 69